Bright Minds Biosciences Inc. (DRUG)
NASDAQ·Healthcare·Biotechnology
$59.69
-0.23%
Mkt Cap $473.06M
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (5 analysts)
$136.50
Range $126.00 – $147.00
Implied Upside
+128.7%
Consensus $136.50 vs current $59.69